Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland Epilepsy and Pregnancy Registers.

Hdl Handle:
http://hdl.handle.net/10147/325167
Title:
Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland Epilepsy and Pregnancy Registers.
Authors:
Campbell, E; Kennedy, F; Russell, A; Smithson, W H; Parsons, L; Morrison, P J; Liggan, B; Irwin, B; Delanty, N; Hunt, S J; Craig, J; Morrow, J
Affiliation:
Neurology Department, Belfast Health and Social Care Trust, Royal Victoria Hospital, Belfast, Co Antrim, UK.
Citation:
Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland Epilepsy and Pregnancy Registers. 2014, 85 (9):1029-34 J. Neurol. Neurosurg. Psychiatr.
Journal:
Journal of neurology, neurosurgery, and psychiatry
Issue Date:
Sep-2014
URI:
http://hdl.handle.net/10147/325167
DOI:
10.1136/jnnp-2013-306318
PubMed ID:
24444855
Abstract:
Antiepileptic drug (AED) exposure during pregnancy increases the risk of major congenital malformations (MCMs). The magnitude of this risk varies by AED exposure. Here we provide updated results from the UK Epilepsy and Pregnancy Register of the risk of MCMs after monotherapy exposure to valproate, carbamazepine and lamotrigine.
Item Type:
Article
Language:
en
Keywords:
PREGNANCY; EPILEPSY; MEDICINES MANAGEMENT
ISSN:
1468-330X

Full metadata record

DC FieldValue Language
dc.contributor.authorCampbell, Een_GB
dc.contributor.authorKennedy, Fen_GB
dc.contributor.authorRussell, Aen_GB
dc.contributor.authorSmithson, W Hen_GB
dc.contributor.authorParsons, Len_GB
dc.contributor.authorMorrison, P Jen_GB
dc.contributor.authorLiggan, Ben_GB
dc.contributor.authorIrwin, Ben_GB
dc.contributor.authorDelanty, Nen_GB
dc.contributor.authorHunt, S Jen_GB
dc.contributor.authorCraig, Jen_GB
dc.contributor.authorMorrow, Jen_GB
dc.date.accessioned2014-08-25T09:17:51Z-
dc.date.available2014-08-25T09:17:51Z-
dc.date.issued2014-09-
dc.identifier.citationMalformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland Epilepsy and Pregnancy Registers. 2014, 85 (9):1029-34 J. Neurol. Neurosurg. Psychiatr.en_GB
dc.identifier.issn1468-330X-
dc.identifier.pmid24444855-
dc.identifier.doi10.1136/jnnp-2013-306318-
dc.identifier.urihttp://hdl.handle.net/10147/325167-
dc.description.abstractAntiepileptic drug (AED) exposure during pregnancy increases the risk of major congenital malformations (MCMs). The magnitude of this risk varies by AED exposure. Here we provide updated results from the UK Epilepsy and Pregnancy Register of the risk of MCMs after monotherapy exposure to valproate, carbamazepine and lamotrigine.en_GB
dc.language.isoenen
dc.rightsArchived with thanks to Journal of neurology, neurosurgery, and psychiatryen_GB
dc.subjectPREGNANCYen_GB
dc.subjectEPILEPSYen_GB
dc.subjectMEDICINES MANAGEMENTen_GB
dc.titleMalformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland Epilepsy and Pregnancy Registers.en_GB
dc.typeArticleen
dc.contributor.departmentNeurology Department, Belfast Health and Social Care Trust, Royal Victoria Hospital, Belfast, Co Antrim, UK.en_GB
dc.identifier.journalJournal of neurology, neurosurgery, and psychiatryen_GB
dc.description.fundingOtheren
dc.description.provinceLeinsteren
dc.description.peer-reviewpeer-reviewen

Related articles on PubMed

All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.